Product Form
inject
API Generic 1
daratumumab
API Generic 2
hyaluronidase
API Strength 1
120 mg/mL
API Strength 2
2000 units/mL
Patent Expiration
Patent Number
- US 10766965
- US 9040050
- US 9187565
- US 7829673
- US 11566079
Brand Generic Search
DARZALEX FASPRO® (daratumumab 120 mg/mL + hyaluronidase 2000 units/mL), inject
Sub Title
DARZALEX FASPRO